QuidelOrtho Corp. (QDEL)
13.25
-0.51
(-3.71%)
USD |
NASDAQ |
Oct 30, 16:00
13.23
-0.02
(-0.15%)
After-Hours: 20:00
QuidelOrtho Enterprise Value : 3.857B for Oct. 30, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 3.857B |
| October 29, 2026 | 3.892B |
| October 28, 2026 | 3.909B |
| October 27, 2026 | 3.880B |
| October 26, 2026 | 3.892B |
| October 23, 2026 | 3.890B |
| October 22, 2026 | 3.873B |
| October 21, 2026 | 3.914B |
| October 20, 2026 | 3.923B |
| October 19, 2026 | 3.824B |
| October 16, 2026 | 3.834B |
| October 15, 2026 | 3.902B |
| October 14, 2026 | 3.899B |
| October 13, 2026 | 3.915B |
| October 12, 2026 | 3.857B |
| October 09, 2026 | 3.869B |
| October 08, 2026 | 3.800B |
| October 07, 2026 | 3.793B |
| October 06, 2026 | 3.811B |
| October 05, 2026 | 3.781B |
| October 02, 2026 | 3.688B |
| October 01, 2026 | 3.661B |
| September 30, 2026 | 3.672B |
| September 29, 2026 | 3.676B |
| September 28, 2026 | 3.692B |
| Date | Value |
|---|---|
| September 25, 2026 | 3.699B |
| September 24, 2026 | 3.682B |
| September 23, 2026 | 3.658B |
| September 22, 2026 | 3.699B |
| September 21, 2026 | 3.694B |
| September 18, 2026 | 3.677B |
| September 17, 2026 | 3.709B |
| September 16, 2026 | 3.688B |
| September 15, 2026 | 3.678B |
| September 14, 2026 | 3.711B |
| September 11, 2026 | 3.757B |
| September 10, 2026 | 3.782B |
| September 09, 2026 | 3.815B |
| September 08, 2026 | 3.866B |
| September 04, 2026 | 3.906B |
| September 03, 2026 | 3.903B |
| September 02, 2026 | 3.905B |
| September 01, 2026 | 3.891B |
| August 31, 2026 | 3.938B |
| August 28, 2026 | 3.959B |
| August 27, 2026 | 3.998B |
| August 26, 2026 | 3.970B |
| August 25, 2026 | 3.980B |
| August 24, 2026 | 3.942B |
| August 21, 2026 | 3.959B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 211.42B |
| Merit Medical Systems, Inc. | 5.482B |
| Globus Medical, Inc. | 9.995B |
| Ceribell, Inc. | 908.62M |
| Align Technology, Inc. | 9.646B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -92.90M |
| Revenue (Quarterly) | 630.20M |
| Total Expenses (Quarterly) | 723.10M |
| EPS Diluted (Quarterly) | -1.360 |
| Gross Profit Margin (Quarterly) | 35.75% |
| Profit Margin (Quarterly) | -14.74% |
| Earnings Yield | -116.3% |
| Normalized Earnings Yield | -54.21 |